Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

15.7K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.7K
Blood Transfusion01:15

Blood Transfusion

2.9K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.9K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.4K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.4K
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

1.9K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ALLOPLUS: allogeneic hematopoietic stem cell transplantation in children and adult people living with human immunodeficiency virus, a retrospective study of the SFGM-TC.

Bone marrow transplantation·2026
Same author

Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control arm.

Journal of hematology & oncology·2026
Same author

PD-L2 is associated with lineage-related transcriptional programs distinct from PD-L1 in primary mediastinal large B-cell lymphoma.

Leukemia·2026
Same author

Prolonged survival with glofitamab in non-diffuse large B-cell lymphoma after CAR T-cell therapy relapse.

Haematologica·2026
Same author

Prognostic value of combined baseline FDG PET/CT radiomic parameters in primary mediastinal B-cell lymphoma.

Blood advances·2026
Same author

Pre-analytical stability of blood samples transported by drone versus ground: a pilot study.

Practical laboratory medicine·2026

Related Experiment Video

Updated: Mar 29, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.7K

Transfusion strategy in hematological intensive care unit: study protocol for a randomized controlled trial.

Sylvain P Chantepie1, Jean-Baptiste Mear2, Lydia Guittet3,4

  • 1Institut d'Hématologie de Basse-Normandie, Centre Hospitalier Universitaire, Côte de Nacre, 14033, Caen, Cedex, France. chantepie-s@chu-caen.fr.

Trials
|November 24, 2015
PubMed
Summary

This study found that transfusing one packed red blood cell (PRBC) unit is as safe as transfusing two units for hematology patients. This single-unit transfusion strategy reduces PRBC use without increasing severe complications.

More Related Videos

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

2.0K
Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

1.6K

Related Experiment Videos

Last Updated: Mar 29, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.7K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

2.0K
Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

1.6K

Area of Science:

  • Hematology
  • Transfusion Medicine
  • Clinical Trials

Background:

  • Packed red blood cell (PRBC) transfusions are common in hematology patients undergoing chemotherapy or hematopoietic stem cell transplantation (HSCT).
  • Restrictive transfusion strategies, including single-unit PRBC transfusions, have shown promise in reducing complications and costs in specific clinical scenarios.
  • Previous retrospective studies suggested the safety and efficacy of a single-unit PRBC transfusion approach.

Purpose of the Study:

  • To prospectively evaluate the safety and non-inferiority of a single-unit PRBC transfusion strategy compared to a standard double-unit strategy.
  • To determine if a single-unit PRBC transfusion policy leads to a similar incidence of severe complications as a double-unit policy.

Main Methods:

  • The '1versus2 trial' is a randomized controlled trial comparing single-unit versus double-unit PRBC transfusions.
  • 230 patients undergoing chemotherapy, autologous (auto) or allogeneic (allo) HSCT in hematology intensive care units were randomized.
  • The primary endpoint is the incidence of severe complications (grade ≥3), including stroke, acute coronary syndrome, heart failure, and death, with a hemoglobin threshold of <8 g/dL for transfusion.

Main Results:

  • The study aimed to demonstrate that a single-unit PRBC transfusion strategy is non-inferior to a double-unit strategy.
  • The sample size calculation of 230 patients was based on a 90% power and a 5% alpha risk to prove non-inferiority.
  • An estimated 93% of hospital stays were complication-free in the context of this non-inferiority hypothesis.

Conclusions:

  • The prospective randomized trial will provide definitive evidence on the safety and efficacy of single-unit PRBC transfusions in hematology patients.
  • Findings are expected to support a shift towards more conservative PRBC transfusion practices, potentially reducing resource utilization and healthcare costs.
  • The study addresses a critical question in transfusion medicine for vulnerable patient populations.